By G HossainPosted on September 2, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease. Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program Post navigation Roche Makes Preclinical IBD Play in $420M+ OMass PactServier Commits up to $530M Into Eye Cancer Deal With IDEAYA